Settlement Agreements and Patent Abuse in the Pharmaceutical Sector: An EU/US Comparison - 2010 Conference

Posted by D. Daniel Sokol

The pharmaceutical sector continues to be one of the main focus areas for competition authorities throughout the world. This conference provides an update on the major developments affecting the sector including the General Court's recent judgment in the AstraZeneca case - the first judgment on dominance and abusive practices in the pharmaceutical sector. Speakers from the European Commission, law firms, economic consultancies and industry include: Chairman: Stephen Kon, Partner, SJ Berwin LLP Dominik Schnichels Head of Pharma Task Force, DG Competition, European Commission Mike Walker Vice President, Charles River Associates Marleen van Kerckhove Partner, Arnold & Porter LLP Asim Varma Partner, Arnold & Porter LLP James S. Venit Partner, Skadden Arps Slate Meagher & Flom LLP David Rosenberg Vice President, Corporate IP Policy, GlaxoSmithKline Cameron Firth Partner, SJ Berwin LLP Gavin Robert Partner, Linklaters LLP Jeffrey Schmidt Partner, Linklaters LLP Mélanie Thill-Tayara Partner, Norton Rose Jordi Faus Partner, Faus & Moliner Abogados Thomas Wessely Partner, Freshfields Bruckhaus Deringer LLP Delegates will receive practical analysis and advice on: AstraZeneca and the Commission's pharma policy Market definition and dominance in the pharma sector following AstraZeneca - what does it mean for your company? Unilateral conduct - when does it risk infringing antitrust rules? A view from the EU and the US EU and US approach to settlement agreements Roundtable: a follow up on the EU inquiry at national level Conference Fees: Standard £650 + 21% TVA = £786.50 In-house lawyers and Government Authorities £550 + 21% TVA = £665.50 Forthcoming GCR Conferences: International Merger Control Major international conference to mark the 20th anniversary of the EU Merger Regulation 28 & 29 September 2010, The Radisson Blu Royal Hotel, Brussels 2010 Antitrust Litigation 12 October 2010, The King's Fund, London GCR's 2010 Competition Law Review In-depth analysis and debate on recent developments in competition law and policy 16 & 17 November 2010, The Conrad Hotel, Brussels 2011 Antitrust Law Leaders Forum 3 - 5 February 2011, Fontainebleau Hotel, Miami Cancellations Cancellations must be received in writing. Cancellations received in writing two weeks before the conference will receive a refund less 10% + TVA. Cancellations received one week before will receive a refund less 50% + TVA. Cancellations received less than a week before the conference will not receive a refund. Substitute delegates are welcome at any time. Unsubscribe To unsubscribe from this briefing please email GCRconferences@GlobalCompetitionReview.com with 'unregister' in the subject field. If you have any queries regarding this briefing please contact us at GCRconferences@GlobalCompetitionReview.com. Data protection Any personal information provided by you will be held on a database and may be shared with other Law Business Research publications. If you do not want us to use your information for marketing purposes please contact GCRconferences@GlobalCompetitionReview.com. Law Business Research Limited 87 Lancaster Road London W11 1QQ Registered in England and Wales number 03281866 Vat registration number GB 681 598586 TVA number pending